Standout Papers
- Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. (1987)
Immediate Impact
2 from Science/Nature 66 standout
Citing Papers
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia
2021 Standout
Works of Stacy Salob being referenced
Behavioral symptoms in Alzheimer's disease: phenomenology and treatment.
1987 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Stacy Salob | 75 | 52 | 62 | 642 | 277 | 12 | 1.1k | |
| Jodie I. Roberts | 79 | 36 | 101 | 538 | 230 | 25 | 1.2k | |
| W. M. Chan | 86 | 57 | 80 | 319 | 161 | 36 | 1.3k | |
| Nils Kappelmann | 24 | 28 | 48 | 200 | 98 | 22 | 1.3k | |
| Sue Jeavons | 8 | 10 | 45 | 452 | 95 | 21 | 1.2k | |
| Michael D. Stensland | 7 | 4 | 31 | 764 | 236 | 30 | 1.1k | |
| Shirley S. Kishiyama | 23 | 37 | 36 | 305 | 193 | 16 | 1.2k | |
| Verena Henkel | 75 | 9 | 60 | 405 | 61 | 33 | 1.3k | |
| Marion U. Goebel | 27 | 41 | 54 | 182 | 152 | 19 | 997 | |
| Magali Volteau | 29 | 27 | 47 | 573 | 295 | 30 | 890 | |
| Daniela Enache | 7 | 6 | 40 | 396 | 166 | 25 | 1.2k |
All Works
Loading papers...